Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Hans Pfüller"'
Publikováno v:
Psychiatry Research. 34:259-270
Eight healthy volunteers were studied under double-blind conditions after acute challenge with the peripheral beta 2-agonist reproterol, either alone or combined with the peripheral indirect cholinomimetic neostigmine. Their responses were also studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1fc41efd5bf971172ab13526d572e35
https://doi.org/10.1016/0165-1781(90)90004-o
https://doi.org/10.1016/0165-1781(90)90004-o
Publikováno v:
Pediatric Nephrology. 12:290-292
Urine concentrations of two high molecular weight proteins, albumin and IgG, and two low molecular weight proteins, alpha1-microglobulin (A1M) and retinol-binding protein (RBP), were measured in 657 healthy children from birth to 18 years of age. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd46ac4f6915c2f1d7381f19a1b4cc1e
https://doi.org/10.1007/s004670050455
https://doi.org/10.1007/s004670050455
Publikováno v:
Psychiatry research. 34(3)
Sensitivity to the centrally active cholinomimetic physostigmine varies dramatically among healthy individuals. The elucidation of the reasons for this variability could contribute to the understanding of the pathophysiology of affective disorders wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c3efd89c5b398db6202ec725a95b38b
https://pubmed.ncbi.nlm.nih.gov/2075225
https://pubmed.ncbi.nlm.nih.gov/2075225
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 1(1)
The centrally active cholinesterase inhibitor physostigmine induces a behavioral syndrome which is thought to represent a model of spontaneous depression. In the present acute trial in 6 healthy volunteers, this model depression was accompanied by cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113c1bf846f5f20b5dec1175e31b95fd
https://pubmed.ncbi.nlm.nih.gov/1967018
https://pubmed.ncbi.nlm.nih.gov/1967018
Publikováno v:
Biological Psychiatry. 22:1495-1499
Growth hormone-releasing hormone (GHRH), recently isolated and characterized by Rivier et al. (1982), is a 44amino acid hypothalamic peptide that stimulates growth hormone (GH) release from somatotrophs. GHRH thus may help our understanding of the pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1e1b77e4dc4feadefe58bcd65f99c9
https://doi.org/10.1016/0006-3223(87)90112-0
https://doi.org/10.1016/0006-3223(87)90112-0
Autor:
Helmut Beckmann, Hans Pfüller, H. M. Schulte, Erik Widerlöv, Rolf Ekman, Klaus-Peter Lesch, G. Laux
Publikováno v:
Biological Psychiatry. 24:162-172
Twenty-four subjects (12 patients with major depressive disorder and 12 controls matched for sex and age) received 100 μg synthetic human corticotropin-releasing hormone (hCRH) as an iv bolus dose. Healthy subjects exhibited a slight, but sustained,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc52ed49ee23667d7941abacb3f5ccb3
https://doi.org/10.1016/0006-3223(88)90271-5
https://doi.org/10.1016/0006-3223(88)90271-5
Autor:
Hans Pfüller, Hans Jürgen Bestmann
Publikováno v:
Angewandte Chemie. 84:528-530
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bd06c752f75dd94363f706a007d1fe2
https://doi.org/10.1002/ange.19720841107
https://doi.org/10.1002/ange.19720841107
Publikováno v:
Pharmacopsychiatry. 21(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c46b6dbe3761236dc9c5c3f596e9c610
https://pubmed.ncbi.nlm.nih.gov/3149754
https://pubmed.ncbi.nlm.nih.gov/3149754
Publikováno v:
Journal of affective disorders. 14(3)
Plasma growth hormone (GH) release after injection of 100 micrograms synthetic human corticotropin-releasing hormone (hCRH) was investigated in 11 patients with major depressive disorder and normal controls matched for gender, age, body weight and ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ed93a7dfc69118343b23bae75b3487d
https://pubmed.ncbi.nlm.nih.gov/2838539
https://pubmed.ncbi.nlm.nih.gov/2838539
Publikováno v:
Pharmacopsychiatry. 21(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a9590e0e5704e9f4883e60e7033639f
https://pubmed.ncbi.nlm.nih.gov/2854277
https://pubmed.ncbi.nlm.nih.gov/2854277